The adenocarcinoma of the larynx: case report with histochemical and immunohistochemical studies

Yıl 2004, Cilt: 13 Sayı: 1, 41 - 45, 10.02.2004

İrfan Bayram Serdar Uğraş Muzaffer Kırış Deniz Reçber

Öz

Adenocarcinomas constitute a histologically diverse group of rare laryngeal neoplasms accounting in aggre- gate for less than 1% of ali laryngeal carcinomas.Adenocarcinoma of the larynx “not othervvise specified” NOS is a very uncommon neoplasia, but it shows a high degree of malignancy. We report a case of ade­ nocarcinoma “NOS” arising in the larynx of a 60 year- old man. Histologically, tumor tissue was composed of only adenocarcinoma component. Histochemically, the adenocarcinoma cells demonstrated Alcian blue pH: 2.5 and PAS reactivity; but did not include argentaffin and argyrophil granules. İmmunohistochemical studies revealed negative reactivity for desmin, HMB45 and NSE. S-100 and chromogranin was focally positive, cytokeratin was diffuse positive.

Anahtar Kelimeler

Adenocarcinoma/pathology/surgery, immunohistochemistry, laryngeal neoplasms/pathology/surgery, laryngectomy

Larenksin adenokarsinomu: Histokimyasal ve immünohistokimyasal değerlendirme ile birlikte olgu sunumu

Öz

Nadir görülen larengeal tümörlerin histolojik olarak farklı bir grubu olan adenokarsinomlar, tüm larenge- al karsinomların %1’inden azında görülür. Bir başka şekilde spesifiye edilmeyen nonspesifik larenks adenokarsinomu çok seyrek görülür ve malignensi derecesi yüksektir. Bu makalede 60 yaşında erkek hastadaki larenks adenokarsinomunu sunuldu. His- tolojik olarak tümör dokusu sadece adenokarsinom komponentiyle sınırlıydı. Histokimyasal olarak tümör hücrelerinde Alcian blue pH: 2.5 ve PAS ile boyan- ma izlendi ve arjentafin ile arjirofil granüller görülme- di. İmmünohistokimyasal olarak desmin, HMB45 ve NSE ile boyanma izlenmezken S-100 ve kromogra- nin ile fokal olarak ve sitokeratin ile diffüz olarak tü- mör hücrelerinin boyandığı görüldü

Anahtar Kelimeler

Adenokarsinom/patoloji/cerrahi, immünohistokimya, larenks neoplazmları/patoloji/cerrahi, larenjektomi.

Kaynakça

• Pilch BZ, Brodsky GL, Godman ML. Pathology of laryngeal malignancies. In: Fried MP, editor. The lar- ynx: a multidisciplinary approach. 1st ed. Boston: Little Brown & Co Inc; 1988. p. 86-99.
• Haberman PJ, Haberman RS 2nd. Laryngeal adenocar- cinoma, not otherwise specified, treated with carbon dioxide laser excision and postoperative radiotherapy. Ann Otol Rhinol Laryngol 1992;101:920-4.
• Whicker JH, Neel HB 3rd, Weiland LH, Devine KD. Adenocarcinoma of the larynx. Ann Otol Rhinol Laryngol 1974;83:487-90.
• Batsakis JG, Luna MA, el-Naggar AK. Nonsquamous carcinomas of the larynx. Ann Otol Rhinol Laryngol 1992;101:1024-6.
• Rosai I. Larynx and trachea. In: Ackerman, editor. Ackerman’s surgical pathology. 8th ed. Missouri: Mosby St. Louis; 1996. p. 327.
• Paladugu RR, Nathwani BN, Goodstein J, Dardi LE, Memoli VE, Gould VE. Carcinoma of the larynx with mucosubstance production and neuroendocrine dif- ferentiation: an ultrastructural and immunohisto- chemical study. Cancer 1982;49:343-9.
• Moisa II, Mahadevia P, Silver CE. Unusual tumors of the larynx. In: Silver CE, editor. Laryngeal cancer. 1st ed. New York: Thieme; 1991. p. 35-43.
• Başerer N, Cevanşir B, Çölhan İ, Ağan M, Yazıcıoğlu E, Koçer M. Larenks adenokarsinomları. Türk Otolarengoloji Arşivi 1985;23:36-43.
• Spiro RH, Hajdu SI, Lewis JS, Strong EW. Mucus gland tumors of the larynx and laryngopharynx. Ann Otol Rhinol Laryngol 1976;85(4 Pt 1):498-503.
• Incandela S, Aragona F, Di Marco G. The adenocarci- noma of the larynx: in aim of a clinic case. Histologic, immuno-histochemistry and electron microscope studies. Rev Laryngol Otol Rhinol (Bord)1999;120:35-8.
• Torre V, Bucolo S, Abbate G, Albiero F, Cicciarello R, Cavallari V. Primary adenocarcinoma of the arytenoid: an ultrastructural study. Pathol Res Pract 2001;197:449- 52.
• Barnes L, Gnepp DR. Diseases of the larynx, hypopharynx and esophagus. In: Barnes L, editor. Surgical pathology of the head and neck. 1st ed. New York: Marcel Dekker; 1985. p. 162-74.